Tetradentate Linker for Amides To be Cleaved by Complexation
CH2-CH2-), 2.44–2.67 (m, 8 H, 2 ϫ -CH2CH2CH3, 2 ϫNHCO-
CH2-CH2-CH2-), 3.19–3.35 (m, 4 H, 2ϫNHCO-CH2-), 3.54 (s, 4
H, 2ϫpy-CH2-), 3.72 (s, 2 H, Ar-CH2-CO-), 3.80 (s, 3 H, -OMe),
18 (0.97 g, 2.8 mmol, 1.0 equiv.) in TFA/CH2Cl2 (1:1, 10 mL) was
added iPr3SiH (1.7 mL, 8.3 mmol, 3.0 equiv.). The mixture was
stirred at room temperature for 2 h, followed by removal of the
6.81 (mc, 2 H, Harom.), 7.09 (mc, 2 H, Harom.), 7.15–7.30 (m, 2 H, solvent under reduced pressure. Column chromatography (CH2Cl2/
H
arom.), 7.59 [t, J = 7.6 Hz, 1 H, C(4) of pyridine] ppm. 13C NMR MeOH, 98:2 Ǟ 90:10) gave title compound 19 as a brown oil
1
(100 MHz, CDCl3): δ = 11.7, 20.0 (2 overlayed signals), 39.6, 44.4,
46.8, 51.5, 55.2, 59.6, 114.0, 123.0, 123.2, 127.5, 129.6, 136.8, 158.3,
171.1 ppm. MS (EI): m/z (%) = 467.4 (100) [M + 1]+, 262.3 (15).
(1.32 g, 2.75 mmol, 100%). H NMR (400 MHz, CDCl3): δ = 0.88
(t, J = 7.3 Hz, 3 H, -CH2-CH3), 1.57–1.82 (m, 2 H, -CH2-CH3),
2.99 (mc, 2 H, -CH2-CH2-CH3), 3.44 [mc, 4 H, -CH2-N(propyl)-
CH2-,-CH2-NH3+], 3.93 (s, 3 H, -CO2Me), 4.33 (s, 2 H, py-CH2-),
7.48 (d, J = 8.2 Hz, 1 H, Harom.), 8.33 (dd, J = 8.1, 2.1 Hz, 1 H,
Harom.), 9.15 (d, J = 2.0 Hz, 1 H, Harom.) ppm. 13C NMR
(100 MHz, CDCl3): δ = 10.9, 18.2, 35.9, 51.7, 52.6, 56.8, 57.1,
116.4, 123.8, 126.2, 138.8, 150.5, 157.0, 165.1 ppm. 19F NMR: δ =
–75.81 ppm. MS (ESI+): m/z (%) = 252.1 (100) [M – 2CF3COO–
H]+.
Methyl 6-Formylnicotinate (16): To a solution of methyl 6-methyl-
nicotinate (15; 2.00 g, 13.2 mmol, 1.0 equiv.) in DMSO (50 mL)
was added iodine (3.35 g, 13.2 mmol, 1.0 equiv.), TFA (3.05 mL,
39.6 mmol, 3.0 equiv.), and tBuI (0.62 mmol, 5.2 mmol, 0.4 equiv.).
The mixture was heated to 120 °C for 3 h. After cooling to room
temperature an aqueous solution of Na2S2O3 (0.1 , 100 mL) and
a solution of NaHCO3 (10%, 120 mL) were added. The aqueous
layer was extracted with CH2Cl2 (4ϫ100 mL), the organic layer
was dried with Na2SO4, and the solvents were evaporated. Column
chromatography (CH2Cl2/MeOH, 98:2) gave title compound 21 as
a brown oil (1.43 g, 8.7 mmol, 65%). The spectroscopic data were
in accordance with those reported in literature.[10]
Methyl 6-({2-[tert-Butoxycarbonyl(pyridine-2-ylmethyl)amino]ethyl-
(propyl)amino}methyl)nicotinate (21): To a solution of methyl ester
19 (1.29 g, 2.69 mmol, 1.0 equiv.) and pyridine-2-carboxaldehyde
(0.256 mL, 2.69 mmol, 1.0 equiv.) in 1,2-DCE (12 mL) was added
NaBH(OAc)3 (0.78 g, 3.77 mmol, 1.4 equiv.). The mixture was
stirred at room temperature for 1.5 h, followed by the addition of
an aqueous solution of NaHCO3 (12 mL). The aqueous layer was
extracted with CH2Cl2 (3ϫ15 mL), the organic layer was dried
with Na2SO4, and the solvents were evaporated to give crude sec-
ondary amine 20 as a brown oil (0.85 g, 2.48 mmol, 92%). To a
solution of crude 20 (0.85 g, 2.48 mmol, 1.0 equiv.) and NEt3
(0.49 mL, 3.52 mmol, 1.4 equiv.) in CH2Cl2 (20 mL) was added
slowly Boc2O (0.70 mL, 3.27 mmol, 1.3 equiv.) at 0 °C. The cooling
bath was removed and the mixture was stirred at room temperature
for 2 h. After addition of H2O (30 mL) the layers were separated,
and the aqueous layer was extracted with CH2Cl2 (3ϫ30 mL). The
combined organic layer was dried with Na2SO4 and the solvents
were evaporated. Column chromatography (CH2Cl2/MeOH, 97:3)
gave title compound 21 as a brown oil (0.84 g, 1.9 mmol, 76%). 1H
NMR (400 MHz, CDCl3): δ = 0.82 (t, J = 7.3 Hz, 3 H, -CH2-CH3),
1.38 (s, 9 H, OtBu), 1.42–1.48 (m, 2 H, -CH2-CH3), 2.42 (mc, 2 H,
-CH2-CH2-CH3), 2.64 [mc, 2 H, -CH2-N(propyl)-CH2], 3.38 (mc, 2
H, -CH2-NBoc-), 3.78 [s, 2 H, py-CH2-N(propyl)-], 4.52 (d, J =
14.8 Hz, 2 H, py-CH2-NBoc-) 3.93 (s, 3 H, -CO2Me), 7.11–7.24 (m,
2 H, Harom.), 7.51–7.65 (m, 2 H, Harom.), 8.21 (d, J = 8.2 Hz, 1 H,
Methyl 6-{[2-(tert-Butoxycarbonylamino)ethylamino]methyl}-
nicotinate (17): To a solution of 16 (1.27 g, 7.69 mmol, 1.0 equiv.)
and N-Boc-ethylenediamine (1.21 mL, 7.69 mmol, 1.0 equiv.) in
1,2-DCE (30 mL) was added NaBH(OAc)3 (2.28 g, 10.8 mmol,
1.4 equiv.). The mixture was stirred at room temperature for 1.5 h.
An aqueous solution of NaHCO3 (30 mL) was added. The aqueous
layer was extracted with CH2Cl2 (3ϫ30 mL), the organic layer was
dried with Na2SO4, and the solvents were evaporated. Column
chromatography (CH2Cl2/MeOH, 98:2 Ǟ 95:5) gave title com-
pound 17 as a brown oil (1.74 g, 5.61 mmol, 73 %). 1H NMR
(400 MHz, CDCl3): δ = 1.42 (s, 9 H, -OtBu), 2.77 (t, J = 5.8 Hz, 2
H, -CH2-NH-CH2-), 3.24 (td, J = 5.8, 5.7 Hz, 2 H, -CH2-NH-Boc),
3.91 (s, 3 H, -CO2Me), 3.96 (s, 2 H, py-CH2-), 5.05 (br. s, 1 H,
-NH-), 7.37 (d, J = 8.1 Hz, 1 H, Harom.), 8.22 (dd, J = 8.0, 2.1 Hz,
1 H, Harom.), 9.13 (br. dd, J = 2.1, 0.6 Hz, 1 H, Harom.) ppm. 13C
NMR (100 MHz, CDCl3): δ = 28.5, 48.9, 52.4, 54.6, 121.8, 124.5,
137.6, 150.6, 156.2, 164.3, 165.8 ppm. MS (ESI+): m/z (%) = 310.1
(100) [M + 1]+, 210.1 (56) [M + 1 – Boc]+. C15H23N3O4 (309.36):
calcd. C 58.24, H 7.49, N 13.58; found C 57.95, H 7.57, N 13.39.
Methyl 6-{[2-(tert-Butoxycarbonylamino)ethyl](propyl)amino}methyl-
nicotinate (18): To a solution of methyl ester 17 (1.60 g, 5.17 mmol,
1.0 equiv.) in CH3CN (40 mL) was added DIEA (5.31 mL,
31.02 mmol, 6.0 equiv.) and propyl bromide (2.35 mL, 25.9 mmol,
5.0 equiv.), and the mixture was stirred under reflux for 15 h. The
solvent was removed under reduced pressure, and the residue was
dissolved in CH2Cl2 (100 mL). The organic layer was washed with
H2O (2ϫ100 mL), dried with Na2SO4, and the solvents were evap-
orated. Column chromatography (CH2Cl2/MeOH, 98:2 Ǟ 95:5)
gave title compound 18 as a brown oil (1.36 g, 3.88 mmol, 75%).
1H NMR (400 MHz, CDCl3): δ = 0.85 (t, J = 7.4 Hz, 3 H, -CH2-
CH3), 1.42 (s, 9 H, -OtBu), 1.45–1.51 (m, 2 H, -CH2-CH3), 2.47 (t,
J = 7.4 Hz, 2 H, -CH2-CH2-CH3); 2.60 [t, J = 6.1 Hz, 2 H, -CH2-
N(propyl)-CH2-], 3.17 (td, J = 6.0, 5.7 Hz, 2 H, -CH2-NHBoc),
3.79, (s, 2 H, py-CH2-), 3.93 (s, 3 H, -CO2Me), 5.15 (br. s, 1 H,
-NH-), 7.50 (d, J = 8.2 Hz, 1 H, Harom.), 8.24 (dd, J = 8.1, 2.2 Hz,
1 H, Harom.), 9.11 (dd, J = 2.2, 0.8 Hz, 1 H, Harom.) ppm. 13C NMR
(100 MHz, CDCl3): δ = 11.8, 20.3, 28.5, 38.5, 52.3, 53.9, 56.7, 60.5,
122.4, 124.5, 137.5, 150.4, 156.1, 165.0, 165.9 ppm. MS (APCI+):
m/z (%) = 352.0 (100) [M + 1]+. C18H29N3O4 (351.44): calcd. C
61.52, H 8.32, N 11.96; found C 61.35, H 8.45, N 11.79.
Harom.), 8.49 (s, 1 H, Harom.), 9.07 (dd, J = 2.1, 0.6 Hz, 1 H, Harom.
)
ppm. 13C NMR (100 MHz, CDCl3): δ = 11.8, 20.5, 28.5, 45.7, 52.3,
52.7, 53.0, 53.5, 56.8, 60.9, 120.7, 121.7, 122.0, 122.1, 124.4, 136.7,
137.5, 149.2, 150.2, 155.8, 159.0, 166.0 ppm. MS (ESI+): m/z (%)
= 443.2 (100) [M + 1]+, 343.2 (42) [M – Boc + 1]+. C24H34N4O4
(442.55): calcd. C 65.14, H 7.74, N 12.66; found C 64.97, H 7.91,
N 12.47.
6-({2-[tert-Butoxycarbonyl(pyridine-2-ylmethyl)amino]ethyl(propyl)-
amino}methyl)nicotinic Acid (22): To a solution of methyl ester 21
(0.82 g, 1.85 mmol, 1.0 equiv.) in MeOH (15 mL) was added an
aqueous solution of NaOH (2 , 1.02 mL, 2.04 mmol, 1.1 equiv.),
and the mixture was heated to reflux for 1.5 h. The solvents were
removed, and the residue was dissolved in H2O (20 mL) and acidi-
fied with 2 HCl (pH 6). The aqueous phase was extracted with
CH2Cl2 (7ϫ20 mL). The combined organic layer was dried with
Na2SO4, and the solvents were evaporated to yield title compound
22 as a white solid (0.71 g, 1.66 mmol, 90%). 1H NMR (400 MHz,
CD3OD): δ = 0.94 (t, J = 7.3 Hz, 3 H, -CH2-CH3), 1.14 (s, 9 H,
OtBu), 1.28–1.39 (m, 2 H, -CH2-CH3), 1.61–1.85 (m, 2 H, -CH2-
CH2-CH3), 3.53 [t, J = 5.4 Hz, 2 H, -CH2-N(propyl)-CH2], 3.91 (t,
J = 5.5 Hz, 2 H, -CH2-NBoc-), 4.55 [s, 2 H, py-CH2-N(propyl)],
4.63 (s, 2 H, py-CH2-NBoc-), 7.31–7.42 (m, 2 H, Harom.), 7.53 (d,
J = 8.1 Hz, 1 H, Harom.), 7.85 (dd, J = 7.8, 7.8 Hz, 1 H, Harom.),
N-[(5-Methoxycarbonyl)pyridine-2-yl]methyl-N-propylethane-1,2-di-
aminium 2,2,2-trifluoroacetate (19): To a solution of methyl ester
Eur. J. Org. Chem. 2009, 4273–4283
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4281